Medical Microfluidic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
The report Global Microfluidic Devices Industry 2016 Market Research Report covers the whole industry outlook with value chain analysis, DRO's, production and sales volumes and figures.
Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries, as well as developed countries, can offer significant revenue generation opportunities.
Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries
Global Microfluidic Devices Market size is projected to be valued $14 Billion by 2024; with a CAGR of 22.3% from 2017 to 2025. Microfluidics is an evolving scientific field with numerous analytical applications and commerci
Microfluidics is a medical approach involving the precise control of small fluid samples for medical analysis. The sample sizes in microfluidics range from microliters to picolitres. At such low volumes, the transportation of fluid is governed significantly by its mass.
Global microfluidic device demand outlook looks impressive for the years ahead, with the market expected to top US$ 21.5 Bn by the end of 2031. This industry survey by Persistence Market Research expects the microfluidic devices market to surge at a CAGR of around 24% over the forecast period of 2021-2031.
Microfluidic devices are referred to as lithographic devices utilized for the diagnosis or analysis of small volumes of fluids to perform the chemical, physiological and biological procedures. Microfluidics devices are gaining popularity across extensive range of diagnostic applications because of need of extremely low quantity of samples and efficiency in data interpretation in comparison to the traditional laboratory equipment.
The Global Microfluidics Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. This report covers market landscape, strategies, merger & acquisition, size, key competitors, company profiles, progressive technological advancement, and expansion of production, segmentation, production, revenue and its growth prospects for the upcoming years.
According to our new research study on “Micropump Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, material, application, end-user,” the market is expected to reach US$ 5,172.86 million by 2028 from US$ 1,553.01 million in 2021. A non-mechanical micropump employs forces directly on a liquid and have a limited flow rate, slower response compared to mechanical micropumps. However, they have shown to be very useful in drug delivery applications owing to their low power consumption. Non-mechanical micropumps are commonly used in micro devices because they can take advantage of physical properties of fluids when the volumes decrease to the micro-size and smaller.
The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.
This report studies the global microfluidics market over the forecast period of 2013 to 2018.The global microfluidics market is valued at $1.59 billion in 2013 and is poised to reach $3.57 billion by 2018, at a CAGR of 17.6%.
Widefield Imaging Systems Market: Japan Regional Market Projected to Witness 2.1X Growth in Terms of Revenue over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025
Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
The microfluidics market is expected to witness market growth at a rate of 23.42% in the forecast period of 2022 to 2029. Data Bridge Market Research report on microfluidics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.
According to the latest research report by IMARC Group, The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. More Info:- https://www.imarcgroup.com/biochips-market
Rapid adoption of advanced technologies in agriculture variable rate to reduce labor cost is a key factor driving atherosclerosis drugs market revenue growth
According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market
The global cell-free fetal DNA testing market is forecast to expand at a CAGR of 10% and thereby increase from a value of US$1.5 Bn in 2023, to US$2.9 Bn by the end of 2030.
According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market
The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. More info:- https://www.imarcgroup.com/microfluidics-market
Moreover, it also aids in maintaining high elongation in urethane acrylates and enhance the flexibility in coatings and inks. The growing construction expenditure across the globe coupled with the increased demand for UV and EB coatings is projected to be the major factors driving the global market. Additionally, the growing demand for automotive inks and coatings shall further boost product demand during the forecast period. However, prolonged exposure to the product can cause adverse effects which may pose threat to the isobornyl acrylate market growth over the forecast duration.
The paper diagnostics Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of paper diagnostics.
Lab-on-Chips Application Market Segmented By application in biotechnological and medical applications with technologies such as medical diagnostics, chemical synthesis and the study of complex cellular process
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.
Single-cell analysis refers to the study of genomics, transcriptomics, proteomics and metabolomics at the single cell level and is applied in cancer research for various chronic and infectious diseases. It is considered important in disclosing population identifying market sub-populations of interest, discovering unique characteristics of individual cells and heterogeneity.
Access Complete Report at - https://www.theinsightpartners.com/reports/perfusion-systems-market Perfusion Systems Market is expected to witness massive growth during the forecast period from 2019-2027, due to Significant Growth of Pharmaceutical and Biotechnology Industries. The Asia Pacific perfusion systems market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on perfusion systems. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.
Global Micro-pump Information, by Type (Mechanical & Non-Mechanical and others), by applications (drug delivery, biomedical, infusion and others) by end users (Hospitals, Clinics, Diagnostic Centers and others) - Forecast to 2027
The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.
The Global Lubricants Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. The microalgae market report includes extensive analysis of market drivers, restraints, market trends and competitive landscape across various geographies. The competitive landscape section includes all market deals of last 2 years of microalgae market. It includes new product launches, mergers and acquisitions, joint ventures, agreements etc.
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Global vitamin deficiency treatment market is expected to rise from its initial estimated value by registering a substantial CAGR during the forecast period of 2019-2026. This rise in market value can be attributed to the increased awareness towards health of people globally. The report contains data of the base year 2018 and historic year 2017.
Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.
BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user’s freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions. In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.
The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/
Micro-Electro-Mechanical Systems (MEMS) Market by Sensor Type (Inertial, Pressure, Microphone, Environmental, and Optical), Actuator Type (Optical, Inkjet Head, Microfluidics, and RF), Vertical, and Geography - Global Forecast to 2022
The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.
The global market is in its growth phase, and is expected to witness significant growth rate of 63.2% during the forecast period, due to surge in applications of organ-on-chip devices in the healthcare sector and increase in demand for organ-on-chip in drug screening.
The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.
The growing incidence of cardiovascular diseases and the technological developments in interventional cardiology devices are driving the demand of the market.
Government initiatives for large scale collaborations of Point-of-Care molecular diagnostics for technical advancements and the changing lifestyle and increasing strategic initiatives such as product launch or collaboration are key factors contributing to the high CAGR of the market during the forecast period.